ReviewEuropean respiratory review : an official journal of the European Respiratory Society2026
Small airways dysfunction: associated factors, clinical aspects and new perspectives.
Review in European respiratory review : an official journal of the European Respiratory Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Scientific interest in small airways emerged in the 1960s. However, despite this early recognition, they long remained a "silent" area of the lung. In this nonsystematic narrative mini-review, we evaluated the different spirometry thresholds used to define small airways dysfunction (SAD), comparing them with other diagnostic techniques. We then examined the various factors associated with SAD, focusing on SAD as defined by spirometry.Maximal mid-expiratory flow, especially below the lower limit of normal (LLN), appears to be the most accurate and reproducible spirometric measure to assess SAD. However, no gold-standard spirometric definition has been endorsed by respiratory academic societies, and forced expiratory volume in 3 s or 6 s <LLN or combined forced expiratory flow could be alternative criteria. Impulse oscillometry or computed tomography scanning represent possible alternative assessment methods, with limitations regarding reproducibility.Globally, prevalence of SAD varies between regions. Air pollution appears to be associated with a higher prevalence of SAD, particularly particulate matter with aerodynamic diameter <2.5 µm. Both active and passive smoking are associated with SAD. SAD is also strongly associated with COPD and the risk of developing it, making SAD a marker of accelerated decline in lung function. Several occupational exposures are associated with SAD, including exposure to organic and inorganic dust. A history of lung infections, especially tuberculosis, is also associated with SAD. Advanced age may also be an associated factor, although the association depends on the criteria used to define SAD. Cardiac events have been associated to SAD, which might explain the association between SAD and higher mortality risk.By integrating these different associations in clinical assessment, it would be possible to screen more reliably and preventively for SAD. This would ensure closer surveillance, which is justified given the strong association with COPD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.